STOCK TITAN

[Form 4] EASTMAN CHEMICAL CO Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Michelle H. Caveness, Senior Vice President and Chief Manufacturing Officer of Eastman Chemical Co. (EMN), reported changes in her beneficial ownership on transactions dated 10/01/2025. She received a payout of 6,715 restricted stock units (RSUs) upon completion of a three-year vesting period, recorded as an acquisition. Simultaneously, 1,636 shares were withheld to satisfy tax liabilities at a reported price of $61.96 per share. After these transactions the filing shows 6,246 shares beneficially owned. The Form 4 was signed by power of attorney on 10/02/2025.

Michelle H. Caveness, Senior Vice President e Chief Manufacturing Officer della Eastman Chemical Co. (EMN), ha riportato cambiamenti nella sua proprietà beneficiaria su operazioni datate 10/01/2025. Ha ricevuto un payout di 6,715 RSU (unita di azioni restritte) al termine di un periodo di vesting di tre anni, registrato come acquisizione. Contemporaneamente, 1.636 azioni sono state trattenute per soddisfare obblighi fiscali a un prezzo dichiarato di $61.96 per azione. Dopo queste operazioni, la filing mostra 6.246 azioni detenute beneficiariamente. Il Form 4 è stato firmato con procura il 10/02/2025.

Michelle H. Caveness, Vicepresidenta Senior y Directora de Manufactura de Eastman Chemical Co. (EMN), informó cambios en su titularidad beneficiosa en transacciones fechadas el 10/01/2025. Ella recibió una liquidación de 6.715 unidades de acciones restringidas (RSU) al completar un periodo de vesting de tres años, registrada como adquisición. Paralelamente, 1.636 acciones fueron retenidas para satisfacer obligaciones fiscales a un precio informado de $61.96 por acción. Después de estas transacciones, la documentación muestra 6.246 acciones de titularidad beneficiaria. El Formulario 4 fue firmado por poder el 10/02/2025.

Michelle H. Caveness, Eastman Chemical Co.의 수석 부사장 겸 제조 최고책임자(CMO)가 2025년 10월 1일자 거래의 수익 소유 변경을 보고했습니다. 그녀는 3년의 vesting 기간이 완료된 후 6,715주 RSU를 지급받았고, 이는 취득으로 기록되었습니다. 동시에 1,636주가 세무 의무를 충당하기 위해 보류되었으며, 주당 가격은 $61.96로 보고되었습니다. 이 거래 후 서류에는 6,246주를 유익하게 보유하고 있는 것으로 나타납니다. Form 4는 2025년 10월 2일에 위임장을 통해 서명되었습니다.

Michelle H. Caveness, vice-présidente principale et directrice de la fabrication d'Eastman Chemical Co. (EMN), a signalé des changements dans son ownership bénéficiaire sur des transactions datées du 10/01/2025. Elle a reçu une attribution de 6 715 unités d'actions restreintes (RSU) à l'issue d'une période d'acquisition de trois ans, enregistrée comme acquisition. Parallèlement, 1 636 actions ont été retenues pour régler des obligations fiscales à un prix déclaré de 61,96 USD par action. Après ces transactions, le dossier indique qu'elle détient 6 246 actions en propriété bénéficiaire. Le Formulaire 4 a été signé par procuration le 02/10/2025.

Michelle H. Caveness, Senior Vice President und Chief Manufacturing Officer von Eastman Chemical Co. (EMN), meldete Änderungen im wirtschaftlichen Eigentum an Transaktionen datiert am 10/01/2025. Sie erhielt eine Auszahlung von 6.715 Restricted Stock Units (RSUs) nach Abschluss einer dreijährigen Vesting-Periode, registriert als Erwerb. Gleichzeitig wurden 1.636 Aktien einbehalten, um Steuerschulden zu decken, zu einem angegebenen Preis von 61,96 USD pro Aktie. Nach diesen Transaktionen zeigt die Einreichung 6.246 Aktien, die wirtschaftlich Eigentum darstellen. Das Form 4 wurde durch Vollmacht am 02/10/2025 unterzeichnet.

ميشيل هـ. كافينس، نائبة الرئيس الأول ورئيسة قسم التصنيع في شركة Eastman Chemical Co. (EMN)، أبلغت عن تغييرات في الملكية المستفيدة في معاملات بتاريخ 10/01/2025. حصلت على مكافأة قدرها 6,715 وحدة أسهم مقيدة (RSUs) عند إتمام فترة الاستحقاق التي مدتها ثلاث سنوات، وتم تسجيلها كاستحواذ. في الوقت نفسه، تم حجز 1,636 سهمًا لتغطية الالتزامات الضريبية بسعر مُبلغ عنه قدره $61.96 للسهم. بعد هذه المعاملات، تُظهر الاستمارة أن لديها 6,246 سهمًا ملكية مستفيدة. تم توقيع النموذج 4 بتوكيل في 02/10/2025.

Michelle H. Caveness,Eastman Chemical Co.(EMN)高级副总裁兼制造总监,报告了在日期为 10/01/2025 的交易中的受益所有权变动。她在为期三年的归属期完成后,获得了 6,715 份受限股票单位(RSU),记作一笔收购。与此同时,1,636 股被扣留以满足税务义务,按每股 $61.96 的披露价格。经过这些交易,备案显示其受益持有股份为 6,246 股。 Form 4 于 2025/10/02 由授权签署。

Positive
  • 6,715 RSUs vested upon satisfaction of the three-year vesting period
  • Beneficial ownership updated to 6,246 shares following the vesting and withholding
Negative
  • 1,636 shares withheld for taxes, reducing issued shares received from the vesting

Insights

Officer vested RSUs and satisfied tax withholding; ownership updated.

The filing documents a routine vesting event where 6,715 RSUs converted to common stock and 1,636 shares were withheld to cover taxes at $61.96 per share. This is a standard compensation settlement for a named officer and updates her direct holdings to 6,246 shares as reported.

This transaction is administrative and expected for executive equity compensation; it does not disclose any new open-market purchases or sales beyond the tax withholding.

Michelle H. Caveness, Senior Vice President e Chief Manufacturing Officer della Eastman Chemical Co. (EMN), ha riportato cambiamenti nella sua proprietà beneficiaria su operazioni datate 10/01/2025. Ha ricevuto un payout di 6,715 RSU (unita di azioni restritte) al termine di un periodo di vesting di tre anni, registrato come acquisizione. Contemporaneamente, 1.636 azioni sono state trattenute per soddisfare obblighi fiscali a un prezzo dichiarato di $61.96 per azione. Dopo queste operazioni, la filing mostra 6.246 azioni detenute beneficiariamente. Il Form 4 è stato firmato con procura il 10/02/2025.

Michelle H. Caveness, Vicepresidenta Senior y Directora de Manufactura de Eastman Chemical Co. (EMN), informó cambios en su titularidad beneficiosa en transacciones fechadas el 10/01/2025. Ella recibió una liquidación de 6.715 unidades de acciones restringidas (RSU) al completar un periodo de vesting de tres años, registrada como adquisición. Paralelamente, 1.636 acciones fueron retenidas para satisfacer obligaciones fiscales a un precio informado de $61.96 por acción. Después de estas transacciones, la documentación muestra 6.246 acciones de titularidad beneficiaria. El Formulario 4 fue firmado por poder el 10/02/2025.

Michelle H. Caveness, Eastman Chemical Co.의 수석 부사장 겸 제조 최고책임자(CMO)가 2025년 10월 1일자 거래의 수익 소유 변경을 보고했습니다. 그녀는 3년의 vesting 기간이 완료된 후 6,715주 RSU를 지급받았고, 이는 취득으로 기록되었습니다. 동시에 1,636주가 세무 의무를 충당하기 위해 보류되었으며, 주당 가격은 $61.96로 보고되었습니다. 이 거래 후 서류에는 6,246주를 유익하게 보유하고 있는 것으로 나타납니다. Form 4는 2025년 10월 2일에 위임장을 통해 서명되었습니다.

Michelle H. Caveness, vice-présidente principale et directrice de la fabrication d'Eastman Chemical Co. (EMN), a signalé des changements dans son ownership bénéficiaire sur des transactions datées du 10/01/2025. Elle a reçu une attribution de 6 715 unités d'actions restreintes (RSU) à l'issue d'une période d'acquisition de trois ans, enregistrée comme acquisition. Parallèlement, 1 636 actions ont été retenues pour régler des obligations fiscales à un prix déclaré de 61,96 USD par action. Après ces transactions, le dossier indique qu'elle détient 6 246 actions en propriété bénéficiaire. Le Formulaire 4 a été signé par procuration le 02/10/2025.

Michelle H. Caveness, Senior Vice President und Chief Manufacturing Officer von Eastman Chemical Co. (EMN), meldete Änderungen im wirtschaftlichen Eigentum an Transaktionen datiert am 10/01/2025. Sie erhielt eine Auszahlung von 6.715 Restricted Stock Units (RSUs) nach Abschluss einer dreijährigen Vesting-Periode, registriert als Erwerb. Gleichzeitig wurden 1.636 Aktien einbehalten, um Steuerschulden zu decken, zu einem angegebenen Preis von 61,96 USD pro Aktie. Nach diesen Transaktionen zeigt die Einreichung 6.246 Aktien, die wirtschaftlich Eigentum darstellen. Das Form 4 wurde durch Vollmacht am 02/10/2025 unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Caveness Michelle H

(Last) (First) (Middle)
200 SOUTH WILCOX DRIVE

(Street)
KINGSPORT TN 37660

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP & Chf. Mfg. Ofc.
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/01/2025 M 6,715 A (1) 7,882 D
Common Stock 10/01/2025 F 1,636(2) D $61.96 6,246 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 10/01/2025 M 6,715 (1) (1) Common Stock 6,715 (1) 0 D
Explanation of Responses:
1. Payout of shares underlying restricted stock units on October 1, 2025, upon satisfaction of the applicable three-year vesting period.
2. Shares of common stock withheld in satisfaction of tax liability upon vesting of the 6,715 restricted stock units.
Remarks:
/s/ Mark D. Austin, by Power of Attorney for Michelle H. Caveness 10/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did EMN officer Michelle Caveness report on 10/01/2025?

The report shows a payout of 6,715 restricted stock units (RSUs) that vested on 10/01/2025.

How many shares were withheld for taxes in the Form 4 for EMN?

1,636 shares of common stock were withheld to satisfy tax liability upon vesting.

What was the withholding price per share reported on the Form 4 (EMN)?

The Form 4 lists a withholding price of $61.96 per share.

How many EMN shares does Michelle Caveness beneficially own after the reported transactions?

The filing reports 6,246 shares beneficially owned following the transactions.

Who signed the Form 4 for Michelle Caveness and when?

The Form 4 was signed by power of attorney by Mark D. Austin on 10/02/2025.
Eastman Chem Co

NYSE:EMN

EMN Rankings

EMN Latest News

EMN Latest SEC Filings

EMN Stock Data

7.12B
113.81M
0.78%
91.74%
2.59%
Specialty Chemicals
Plastic Materials, Synth Resins & Nonvulcan Elastomers
Link
United States
KINGSPORT